1. All Products
  2. METRONIDAZOLE benzoate,eq.125mg/5ml base,oral susp,100-120ml
Public Pricelist

METRONIDAZOLE benzoate,eq.125mg/5ml base,oral susp,100-120ml

https://medicalguidelines.msf.org/en/node/440
https://unicat.msf.org/cat/product/12165
NST DORAMETN1S1

Valid Article

6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.5.1 - Antiamoebic and antigiardiasis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01AB01
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

METRONIDAZOLE

Therapeutic Action

Antiprotozoal, antibacterial

Indications

Amoebiasis, giardiasis, trichomoniasis

Bacterial vaginitis, infections due to anaerobic bacteria

Instructions for use

The oral suspension and 250 mg tablets are intended for paediatric use.

Oral metronidazole may be replaced by oral tinidazole.

Storage

  • Below 25° - Protect from sunlight
  • Oral suspension: read the manufacturer's instructions on the packaging.